Mayo Clinic Hospital

Jacksonville, Florida 32224

3 studies enrolling now · 17 studies all time

What they study most

Acute Ischemic Stroke, Advanced Solid Tumor, Amyotrophic Lateral Sclerosis, Colorectal Neoplasms, Fractures, Glioblastoma, Glioblastoma (GBM), Graft Versus Host Disease, Acute, Idiopathic Pulmonary Fibrosis, Ischemic Stroke, Kidney Transplant Rejection, Leiomyosarcoma

Studies at this site

• Virtual Reality in Reducing Acute Orthopedic Pain — Recruiting now
• A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients — Recruiting now
• A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations — Running, not enrolling
• Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML — Running, not enrolling
• Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid Tumors — Completed
• A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD — Running, not enrolling
• A Phase 1/2 Study of Safety and Tolerability of MT-125 With Chemoradiation in Patients With Newly Diagnosed MGMT Methylated Glioblastoma — Starting soon
• Evaluation of Oral ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) — Paused
• Multi-arm Optimization of Stroke Thrombolysis — Completed
• Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants — Completed
• Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA) — Status unconfirmed
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB100 Administered Orally to Adults With Amyotrophic Lateral Sclerosis — Completed
• Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas — Completed
• Study of Tepotinib Combined With Cetuximab in Participants With Left-Sided RAS/BRAF Wild Type Metastatic Colorectal Cancer (PERSPECTIVE) — Stopped early
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease — Stopped early
• Early Mobilization of Ischemic Stroke Patients Within 24-hours After Intravenous-Tissue Plasminogen Activator (IV-tPA) — Completed